期刊文献+

靶向MRI纳米探针在胰腺神经内分泌肿瘤诊断中的应用

The application of the target MRI nano probe in the diagnosis of pancreatic neuroendocrine tumor
下载PDF
导出
摘要 目的:探讨靶向磁共振成像(MRI)纳米探针在胰腺神经内分泌肿瘤(pNENs)诊断中的应用价值。方法:选取60只雄性昆明裸鼠,按随机数字表法分为A组、B组、C组,每组20只,建立pNENs细胞株QGP-1原位移植瘤裸鼠模型。A组注射负载超顺磁性四氧化三铁纳米粒子(SPIO)的纳米胶束,B组注射5 mg Fe/kg负载SPIO和Octreotide的纳米胶束,C组注射10 mg Fe/kg负载SPIO和Octreotide的纳米胶束,分别于注射前及注射后0.5 h、1 h、2 h、6 h、12 h进行MRI扫描,分析靶向MRI纳米探针对pNENs的诊断价值。结果:在MTT比色试验中,3组细胞活性比较差异无统计学意义(P>0.05)。3组注射后0.5 h、1 h、2 h、6 h、12 h的横向弛豫时间(T2)均较注射前明显下降,A组各时间段T2下降比例明显低于B组,B组各时间段T2下降比例明显低于C组,差异均有统计学意义(均P<0.05);在普鲁士蓝染色试验中,A组、B组、C组细胞内均可见蓝色颗粒,A组蓝色颗粒数明显少于B组,B组明显少于C组,差异有统计学意义(均P<0.05)。结论:负载SPIO和Octreotide的纳米探针对pNENs细胞株QGP-1原位癌细胞具有良好的靶向性,对pNENs早期诊断具有较大的应用潜力。 Objective:To investigate the value of the target magnetic resonance(MRI)nano probe in the diagnosis of pancreatic neuroendocrine tumor(pNENs).Methods:60 male Kunming nude mice were randomized to 3 groups(20 cases per group):group A,group B and group C.A nude mouse model of P-NENs cell line QGP-1 in situ xenografts was established.Group A mice were injected with nano micelles loaded with superparamagnetic iron oxide nanoparticles(SPIO),group B mice were injected with 5 mg Fe/kg loaded nanomicelles of SPIO and Octreotide,and mice in group C were injected with 10 mg Fe/kg loaded nanomicelles of SPIO and Octreotide.Before injection and after 0.5 h,1 h,2 h,6 h and 12 h of injection,the MRI scanning was conducted.Results:In the MTT test,no significant difference was found in the cell activity among the three groups(P>0.05).After 0.5 h,1 h,2 h,6 h and 12 h of injection,the lateral relaxation time(T2)was significantly decreased in all groups,and the decrease was the most significant in group C(P<0.05).In Prussian blue staining test,the number of blue particles was the highest in group C(P<0.05).Conclusion:The nanoscale probes loaded with SPIO and Octreotide had good targeting ability on the pNENs cell line QGP-1 in situ cancer cells.It might possess great potential for the early diagnosis of pNENs.
作者 冯瑞枝 罗宴吉 Feng Ruizhi;Luo Yanji(Medical Imaging Department,The Third People’s Hospital of Dongguan,Dongguan 523320,China;Medical Imaging Department,The First Affiliated Hospital of Sun yat-sen University,Guangzhou 510080,China)
出处 《广西医科大学学报》 CAS 2019年第3期355-358,共4页 Journal of Guangxi Medical University
基金 广东省自然科学基金资助项目(No.2014A030310484)
关键词 靶向 磁共振 纳米探针 胰腺神经内分泌肿瘤 诊断 target magnetic resonance nanoscale probe pancreatic neuroendocrine tumor diagnosis
  • 相关文献

参考文献8

二级参考文献96

  • 1Theodoros E Pavlidis,Kyriakos Psarras,Nikolaos G Symeonidis,Efstathios T Pavlidis,Athanasios K Sakantamis.Current surgical management of pancreatic endocrine tumor liver metastases[J].Hepatobiliary & Pancreatic Diseases International,2011,10(3):243-247. 被引量:5
  • 2Takehiro Okabayashi,Yasuo Shima,Tatsuaki Sumiyoshi,Akihito Kozuki,Satoshi Ito,Yasuhiro Ogawa,Michiya Kobayashi,Kazuhiro Hanazaki.Diagnosis and management of insulinoma[J].World Journal of Gastroenterology,2013,19(6):829-837. 被引量:89
  • 3Jonathan Strosberg,Roman Casciano,Lee Stern,Rohan Parikh,Maruit Chulikavit,Jacob Willet,Zhimei Liu,Xufang Wang,Krzysztof J Grzegorzewski.United States-based practice patterns and resource utilization in advanced neuroendocrine tumor treatment[J].World Journal of Gastroenterology,2013,19(15):2348-2354. 被引量:1
  • 4张龙江,祁吉.分子影像学探针的研究与进展[J].国外医学(临床放射学分册),2006,29(5):289-293. 被引量:14
  • 5Ehehalt F, Saeger H D, Schmidt C M, et al. Neuroendocrine tumors of the pancreas[J]. Oncologist, 2009, 14 (5):456-467.
  • 6Franko J, Feng W, Yip L, et al. Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients [J]. J Gastrointest Surg, 2010,14(3):541-548.
  • 7Jeong H K, Roh S Y, Hong S H, et al. Pancreatic endocrine tumors: a report on a patient treated with sorafenib [J]. J Korean Med Sci, 2011, 26(7): 954-958.
  • 8Wang D S, Zhang D S, Qiu M Z, et al. Prognostic factors and survival in patients with neuroendocrine tumors of the pancreas [J]. Tumour Biol, 2011, 32(4):697-705.
  • 9Panzuto F, Boninsegna L, Fazio N, et al. Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression [J]. J Clin Oncol, 2011, 29(17): 2372-2377.
  • 10Oberheim N A, Kim A, Farkas R L, et al. Giant pancreatic tumor with clinical characteristics of insulinoma but without common pathologic features [J]. Endocr Pract, 2011, 17(2): e12-16.

共引文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部